1. A multinational assessment of work‐related productivity loss and indirect costs from a survey of patients with psoriasis. (1st September 2020) Authors: Villacorta, R.; Teeple, A.; Lee, S.; Fakharzadeh, S.; Lucas, J.; McElligott, S. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multinational assessment of work‐related productivity loss and indirect costs from a survey of patients with psoriasis. (29th January 2020) Authors: Villacorta, R.; Teeple, A.; Lee, S.; Fakharzadeh, S.; Lucas, J.; McElligott, S. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation of psoriasis activity with socioeconomic status: cross‐sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). (1st October 2018) Authors: Kimball, A.B.; Augustin, M.; Gordon, K.B.; Krueger, G.G.; Pariser, D.; Fakharzadeh, S.; Goyal, K.; Calabro, S.; Lee, S.; Lin, R.; Li, N.; Srivastava, B.; Guenther, L. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR). (1st July 2014) Authors: Kimball, A.B.; Leonardi, C.; Stahle, M.; Gulliver, W.; Chevrier, M.; Fakharzadeh, S.; Goyal, K.; Calabro, S.; Langholff, W.; Menter, A. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR)3. (16th July 2014) Authors: Kimball, A.B.; Leonardi, C.; Stahle, M.; Gulliver, W.; Chevrier, M.; Fakharzadeh, S.; Goyal, K.; Calabro, S.; Langholff, W.; Menter, A.; the PSOLAR Steering Committee Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). (30th March 2016) Authors: Menter, A.; Papp, K.A.; Gooderham, M.; Pariser, D.M.; Augustin, M.; Kerdel, F.A.; Fakharzadeh, S.; Goyal, K.; Calabro, S.; Langholff, W.; Chavers, S.; Naessens, D.; Sermon, J.; Krueger, G.G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 7(2016:Jul.) Page Start: 1148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extension of ustekinumab maintenance dosing interval in moderate‐to‐severe psoriasis: results of a phase IIIb, randomized, double‐blinded, active‐controlled, multicentre study (PSTELLAR). (16th November 2017) Authors: Blauvelt, A.; Ferris, L.K.; Yamauchi, P.S.; Qureshi, A.; Leonardi, C.L.; Farahi, K.; Fakharzadeh, S.; Hsu, M.‐C.; Li, S.; Chevrier, M.; Smith, K.; Goyal, K.; Chen, Y.; Muñoz‐Elías, E.J.; Callis Duffin, K. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Extension of ustekinumab maintenance dosing interval in moderate‐to‐severe psoriasis: results of a phase IIIb, randomized, double‐blinded, active‐controlled, multicentre study (PSTELLAR). (1st December 2017) Authors: Blauvelt, A.; Ferris, L.K.; Yamauchi, P.S.; Qureshi, A.; Leonardi, C.L.; Farahi, K.; Fakharzadeh, S.; Hsu, M.‐C.; Li, S.; Chevrier, M.; Smith, K.; Goyal, K.; Chen, Y.; Muñoz‐Elías, E.J.; Callis Duffin, K. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Risk of malignancies associated with ustekinumab. (1st December 2017) Authors: Greenspan, A.; Marty‐Ethgen, P.; Fakharzadeh, S. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk of malignancies associated with ustekinumab. (1st January 2018) Authors: Greenspan, A.; Marty‐Ethgen, P.; Fakharzadeh, S. Journal: British journal of dermatology Issue: Volume 178:Number 1(2018) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗